Tejaskumar Pankajbhai Pathak

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Novartis Ag, Yale University. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tejaskumar Pankajbhai Pathak. Retrieved from https://idiyas.com/inventor/tejaskumar-pankajbhai-pathak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

Years Active: 2019-2026

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760031 - Pyridine-3-carboxylate compounds as CA1.2 activators (2026-10-13),

2. 12365690 - Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyrodine-3-carboxylate as Ca1.2 activators (2025-07-22),

3. 11919911 - Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[b]pyridine-3-carboxylate and methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate as CAV1.2 activators (2024-03-05),

4. 11453679 - Methyl 2-methyl-5-oxo-1,4,5,7-tetradhydrofuro[3,4-b]pyridine-3-carboxylate compounds as Ca1.2 activators (2022-09-27),

5. 10294275 - Site-selective functionalization of glycopeptide antibiotics (2019-05-21),

Title: Innovations of Tejaskumar Pankajbhai Pathak

Introduction

Tejaskumar Pankajbhai Pathak is a notable inventor based in Boston, MA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for various mental health disorders. With a total of four patents to his name, his work is recognized for its potential impact on treatment options.

Latest Patents

Among his latest patents are two innovative compounds: Methyl (R)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1H-cyclopenta[B]pyridine-3-carboxylate and methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate. These compounds are identified as CaV1.2 activators and are aimed at treating a range of conditions including schizophrenia, bipolar disorder, major depressive disorder, substance use disorder, ADHD, Phelan-McDermid Syndrome, autism spectrum disorder, multiple sclerosis, frontotemporal dementia, Alzheimer's disease, Brugada Syndrome, Short QT syndrome, and early repolarization syndrome.

Career Highlights

Tejaskumar has worked with prominent organizations such as Novartis AG and Yale University. His experience in these institutions has allowed him to collaborate with leading experts in the field, enhancing his research and development capabilities.

Collaborations

Some of his notable coworkers include James Neef and Amir Masoud Sadaghiani. Their collaborative efforts have contributed to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Tejaskumar Pankajbhai Pathak's work exemplifies the spirit of innovation in the pharmaceutical sector. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for complex health issues.

Profile summary based on public USPTO records.